Negara: Australia
Bahasa: Inggris
Sumber: Department of Health (Therapeutic Goods Administration)
idarubicin hydrochloride, Quantity: 1 mg/mL
Pfizer (Perth) Pty Ltd
Injection, intravenous infusion
Excipient Ingredients: glycerol; hydrochloric acid; water for injections
Intravenous Infusion
1 X 5 mL
(S1) This Schedule is intentionally blank
SOUTH AFRICA: Acute non-lymphocytic leukaemia (ANLL), including acute myeloblastic leukaemia (AML) in adults, for remission induction as front-line therapy, or for remission induction in relapsed or refractory patients. ZAVEDOS, in combination with cytarabine, is indicated for the first remission induction-line treatment of previously untreated children with acute myeloid leukaemia (AML)
Visual Identification: Red-orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Listed (Export Only)
2023-02-17